Professor | Dr. Panjwani Center for Molecular Medicine and Drug Research | Pakistan
Prof. Zaheer Ul-Haq is an internationally recognized scientist whose scholarly leadership has significantly advanced Medicinal Chemistry through the integration of computational strategies, rational drug design, and experimental validation. His work in Medicinal Chemistry is characterized by a strong focus on structure–activity relationships, molecular docking, virtual screening, and mechanistic interpretation of biomolecular interactions, establishing him as a central contributor to modern Medicinal Chemistry research. With an extensive body of peer-reviewed publications, he has delivered high-impact contributions to Medicinal Chemistry across diverse therapeutic areas, including enzyme inhibition, receptor–ligand interactions, infectious diseases, metabolic disorders, inflammation, and neurodegenerative conditions. His research outputs demonstrate both depth and breadth in Medicinal Chemistry, bridging fundamental theory with translational relevance and reinforcing the discipline’s role in contemporary drug discovery. A defining feature of his Medicinal Chemistry portfolio is the successful collaboration with multidisciplinary teams spanning chemistry, biology, pharmacology, and computational sciences, resulting in widely cited studies published in leading international journals. These collaborations have strengthened global research networks in Medicinal Chemistry and contributed to the validation of computational approaches as reliable tools for lead identification and optimization. His publication record reflects sustained productivity and influence, with numerous articles serving as reference points for subsequent Medicinal Chemistry investigations. Beyond publication metrics, his research has delivered societal impact by accelerating early-stage drug discovery, reducing experimental costs, and supporting the identification of safer and more effective therapeutic candidates, thereby reinforcing the practical value of Medicinal Chemistry in addressing global health challenges. Prof. Zaheer Ul-Haq has also played an influential role in shaping scientific discourse in Medicinal Chemistry through mentorship, peer review, and collaborative authorship, fostering rigorous standards and innovation within the field. His scholarly contributions continue to guide emerging researchers and inform industry-relevant strategies, underscoring his standing as a leading authority in Medicinal Chemistry with enduring academic and societal significance. Google Scholar profile: 6699 citations, h-index 42, i10-index 165.
Profile: Google Scholar
Featured Publications
1. Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2021). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 39(7), 2607–2616.
2. Khan, I., Ali, S., Hameed, S., Rama, N. H., Hussain, M. T., Wadood, A., Uddin, R., et al. (2010). Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. European Journal of Medicinal Chemistry, 45(11), 5200–5207.
3. Choudhary, M. I., Nawaz, S. A., Ul-Haq, Z., Lodhi, M. A., Ghayur, M. N., Jalil, S., et al. (2005). Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochemical and Biophysical Research Communications, 334(1), 276–287.
4. Hussain, M. R. M., Baig, M., Mohamoud, H. S. A., Ul-Haq, Z., Hoessli, D. C., et al. (2015). BRAF gene: From human cancers to developmental syndromes. Saudi Journal of Biological Sciences, 22(4), 359–373.
5. Khan, K. M., Rahim, F., Halim, S. A., Taha, M., Khan, M., Perveen, S., et al. (2011). Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking. Bioorganic & Medicinal Chemistry, 19(14), 4286–4294.